Get the Stockscreener App
8.37
2.07%
0.17
After Hours:
8.31
-0.06
-0.72%
Avantor Inc stock is traded at $8.37, with a volume of 16.23M.
It is up +2.07% in the last 24 hours and up +5.55% over the past month.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
See More
Previous Close:
$8.20
Open:
$8.28
24h Volume:
16.23M
Relative Volume:
1.47
Market Cap:
$5.66B
Revenue:
$6.55B
Net Income/Loss:
$-530.20M
P/E Ratio:
-10.76
EPS:
-0.7777
Net Cash Flow:
$495.00M
1W Performance:
+4.62%
1M Performance:
+5.55%
6M Performance:
-39.65%
1Y Performance:
-45.65%
1-Day Range:
$8.26
$8.485
1-Week Range:
$7.645
$8.485
52-Week Range:
$7.265
$16.17
Avantor Inc Stock (AVTR) Company Profile
Name
Avantor Inc
Sector
Industry
Phone
(610) 386-1700
Address
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Compare AVTR vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVTR
Avantor Inc
|
8.37 | 5.54B | 6.55B | -530.20M | 495.00M | -0.7777 |
ISRG
Intuitive Surgical Inc
|
468.36 | 165.94B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.52 | 44.30B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
80.73 | 38.96B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
47.93 | 38.69B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
228.80 | 33.61B | 5.40B | 1.49B | 1.78B | 10.12 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-05-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-17-25 | Downgrade | Jefferies | Hold → Underperform |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-04-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-30-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-01-25 | Downgrade | Jefferies | Buy → Hold |
| Apr-29-25 | Downgrade | Goldman | Buy → Neutral |
| Apr-28-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-28-25 | Downgrade | Stifel | Buy → Hold |
| Apr-28-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-17-25 | Downgrade | UBS | Buy → Neutral |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jul-10-24 | Downgrade | Citigroup | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-11-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Jul-31-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-21-23 | Initiated | RBC Capital Mkts | Outperform |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Oct-05-22 | Upgrade | Citigroup | Neutral → Buy |
| Sep-14-22 | Downgrade | Cowen | Outperform → Market Perform |
| Sep-09-22 | Downgrade | Cleveland Research | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-30-21 | Resumed | Raymond James | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Aug-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jun-04-21 | Initiated | Goldman | Buy |
| Apr-29-21 | Upgrade | Stifel | Hold → Buy |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Aug-02-19 | Initiated | Cleveland Research | Neutral |
| Jun-14-19 | Initiated | Janney | Buy |
| Jun-12-19 | Initiated | Raymond James | Outperform |
| Jun-11-19 | Initiated | Goldman | Buy |
| Jun-11-19 | Initiated | Guggenheim | Buy |
| Jun-11-19 | Initiated | JP Morgan | Overweight |
| Jun-11-19 | Initiated | Jefferies | Buy |
| Jun-11-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-11-19 | Initiated | Piper Jaffray | Neutral |
| Jun-11-19 | Initiated | RBC Capital Mkts | Outperform |
| Jun-11-19 | Initiated | Robert W. Baird | Outperform |
| Jun-11-19 | Initiated | SunTrust | Buy |
| Jun-11-19 | Initiated | UBS | Buy |
| Jun-11-19 | Initiated | William Blair | Outperform |
View All
Avantor Inc Stock (AVTR) Latest News
Avantor stock up as new lab capabilities improve biopharma support - MSN
Avantor India Expands its Strategic Collaboration with Parafilm to Serve the Indian Laboratory Consumables Market - ANTARA News
Research Tools & Consumables Stocks Q4 In Review: Avantor (NYSE:AVTR) Vs Peers - TradingView — Track All Markets
Avantor slides on revised outlook, revenue miss - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Investors to Reach Out - ACCESS Newswire
Barclays Maintains Avantor(AVTR.US) With Sell Rating, Cuts Target Price to $7 - Moomoo
A Look At Avantor’s Valuation As It Expands Its North American Quality Control Hub - Yahoo Finance
Avantor Stock Up as New Lab Capabilities Improve Biopharma Support - Zacks Investment Research
Radnor-based Avantor opens St. Louis facility - Pennsylvania Business Report -
Avantor Inc stock (US05352A1007): Why supply chain resilience matters more now for investors - AD HOC NEWS
Avantor Adds Microbial, Stability Testing Capabilities to St. Louis Manufacturing Site - marketscreener.com
Analysts hold neutral stance on Avantor, Inc. (AVTR) amid lower valuation expectations - MSN
Avantor expands strategic collaboration with Parafilm to serve Indian lab consumables market - BioSpectrum India
Avantor expands quality control testing at St. Louis facility By Investing.com - Investing.com Canada
Avantor expands quality control testing at St. Louis facility - Investing.com
Avantor Inc stock (US05352A1007): Why supply chain resilience matters more now - AD HOC NEWS
Avantor® Enhances U.S. Biomanufacturing Infrastructure with Expanded Stability and Microbial Testing Facility - PR Newswire
Analysts Hold Neutral Stance on Avantor, Inc. (AVTR) Amid Lower Valuation Expectations - Insider Monkey
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Stockholders to Reach Out - ACCESS Newswire
AVTR Technical Analysis & Stock Price Forecast - Intellectia AI
Should I invest in Avantor Inc before earningsWeekly Risk Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Avantor Inc stock (US05352A1007): Is its lab supply dominance strong enough for U.S. investor upside - AD HOC NEWS
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avantor, Inc. (AVTR) And Encourages Stockholders to Connect - ACCESS Newswire
Avantor CFO Brent Jones to depart by June 2026 - MSN
Alpha Buying: Following Conviction, Not the CrowdAvantor (NYSE:AVTR), Baxter International (NYSE:BAX) - Benzinga
How Avantor’s (AVTR) CFO Transition Could Shape Its Financial Discipline and Strategic Execution - simplywall.st
Avantor CFO Brent Jones to Depart by June 2026 - MyChesCo
AVTR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Avantor, Inc. (AVTR) Stock Price, News, Quote & History - Yahoo! Finance Canada
[Form 4] Avantor, Inc. Insider Trading Activity - Stock Titan
Evercore Maintains Avantor(AVTR.US) With Hold Rating, Cuts Target Price to $8.5 - Moomoo
Sectors Review: Is Avantor Inc still a buy after recent gains2026 Growth vs Value & Accurate Buy Signal Notifications - baoquankhu1.vn
Avantor® to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026 - Sahm
Avantor, Inc. (AVTR) Q1 Earnings Meet Estimates - MSN
Why The Narrative Around Avantor (AVTR) Is Shifting After Target Cuts And Leadership Changes - Yahoo Finance
Avantor to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026 - bitget.com
Avantor, Inc. (AVTR) stock price, news, quote and history - Yahoo Finance Singapore
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Avantor (AVTR) and Veeva Systems (VEEV) - The Globe and Mail
2026-04-02 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Shareholders to Learn More About the Investigation | NYSE:AVTR | Press Release - Stockhouse
ESAB Corporation Announces CFO Transition - Business Wire
Avantor CFO R Brent Jones to depart - MSN
SG Americas Securities LLC Acquires 272,093 Shares of Avantor, Inc. $AVTR - MarketBeat
Avantor® Announces CFO Transition - Sahm
Avantor CFO R. Brent Jones to depart by late June - Investing.com Canada
Avantor, Inc. (AVTR) Stock forecasts - Yahoo Finance UK
Avantor, Inc. (AVTR) Stock Forecasts - Yahoo Finance
Avantor stock holds at Market Perform as CFO departs, guidance intact - Investing.com India
How Investors Are Reacting To Avantor (AVTR) CFO Succession and Interim Finance Leadership Shift - simplywall.st
Avantor, Inc. Announces CFO Transition in April 2026 Press Release - Minichart
R. Brent Jones to Leave as Executive Vice President of Avantor, Inc., Effective on or Before June 24, 2026 - marketscreener.com
Avantor Inc Stock (AVTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.06%
1.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):